Table 2.
Correlations of other diseases with psoriasis and psoriatic arthritis disease status
| N = 629 | Psoriatic arthritis (n = 102) | Psoriasis (n = 527) | |||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | p-valueζ | Odds Ratio | 95% C.I. | |
| Dermatitis | 12 | 11.76% | 57 | 10.82% | 0.73 | 1.10 | 0.57–2.13 |
| Pyoderma | 1 | 0.98% | 16 | 3.04% | 0.33 | 0.32 | 0.04–2.41 |
| Hypertension | 4 | 3.92% | 7 | 1.33% | 0.09 | 3.03 | 0.87–10.55 |
| Hyperlipidemia | 3 | 2.94% | 1 | 0.19% | 0.02* | 15.94 | 1.64-154.80 |
| Gout | 5 | 4.90% | 7 | 1.33% | 0.03* | 3.83 | 1.19-12.31 |
| Axial spondylopathy | 11 | 10.78% | 0 | 0.00% | <0.01* | 1.12 | 1.05-1.20 |
| Allergic rhinitis | 6 | 5.88% | 4 | 0.76% | <0.01* | 8.17 | 2.26-29.50 |
| Chronic bronchitis | 1 | 0.98% | 1 | 0.19% | 0.30 | 5.21 | 0.32–83.94 |
| Hepatitis (non-B, non-C) | 3 | 2.94% | 5 | 0.95% | 0.13 | 0.93 | 0.40–2.16 |
| Hepatitis B carrier | 4 | 3.92% | 21 | 3.98% | 1.00 | 1.05 | 0.33–3.30 |
| Hepatitis C infection | 5 | 4.90% | 20 | 3.80% | 0.79 | 1.16 | 0.41–3.28 |
*indicates p < 0.05 by Chi square